Company intelligence / Profile preview

Axxora

San Diego, California, USAaxxora.com ↗

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Axxora was a specialized life sciences company that operated as a global marketplace and distributor for high-quality research reagents. The company integrated several niche brands, including Alexis Biochemicals and Apotech, to provide a curated catalog of antibodies, proteins, and small molecules. Its product portfolio primarily focused on critical research areas such as apoptosis, signal transduction, and inflammation. In 2007, Axxora was acquired by Enzo Biochem for approximately $16 million, becoming a core component of the Enzo Life Sciences division and expanding its international commercial footprint.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeMonoclonal antibodyRecombinant proteinPeptides
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Axxora.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axxora.

Explore the full profile